1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Personalized Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Hematopoietic Stem Cell
  • 1.3.3 Skeletal Muscle Stem Cell
  • 1.3.4 Mesenchymal Stem Cells
  • 1.3.5 Lymphocytes
  • 1.3.6 Others
• 1.4 Market by Application
  • 1.4.1 Global Personalized Cell Therapy Market Share by Application: 2020 VS 2026
  • 1.4.2 Cardiovascular Diseases
  • 1.4.3 Neurological Disorders
  • 1.4.4 Inflammatory Diseases
  • 1.4.5 Diabetes
  • 1.4.6 Cancer
  • 1.4.7 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Cell Therapy Market Perspective (2015-2026)
• 2.2 Personalized Cell Therapy Growth Trends by Regions
  • 2.2.1 Personalized Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Personalized Cell Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Personalized Cell Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Personalized Cell Therapy Industry Dynamic
  • 2.3.1 Personalized Cell Therapy Market Trends
  • 2.3.2 Personalized Cell Therapy Market Drivers
  • 2.3.3 Personalized Cell Therapy Market Challenges
  • 2.3.4 Personalized Cell Therapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Personalized Cell Therapy Players by Market Size
  • 3.1.1 Global Top Personalized Cell Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Personalized Cell Therapy Revenue Market Share by Players (2015-2020)
• 3.2 Global Personalized Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Personalized Cell Therapy Revenue
• 3.4 Global Personalized Cell Therapy Market Concentration Ratio
  • 3.4.1 Global Personalized Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Cell Therapy Revenue in 2019
• 3.5 Key Players Personalized Cell Therapy Area Served
• 3.6 Key Players Personalized Cell Therapy Product Solution and Service
• 3.7 Date of Enter into Personalized Cell Therapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cell Therapy Breakdown Data by Type

• 4.1 Global Personalized Cell Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Personalized Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Personalized Cell Therapy Breakdown Data by Application

• 5.1 Global Personalized Cell Therapy Historic Market Size by Application (2015-2020)
• 5.2 Global Personalized Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Personalized Cell Therapy Market Size (2015-2026)
• 6.2 North America Personalized Cell Therapy Market Size by Type (2015-2020)
• 6.3 North America Personalized Cell Therapy Market Size by Application (2015-2020)
• 6.4 North America Personalized Cell Therapy Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Personalized Cell Therapy Market Size (2015-2026)
• 7.2 Europe Personalized Cell Therapy Market Size by Type (2015-2020)
• 7.3 Europe Personalized Cell Therapy Market Size by Application (2015-2020)
• 7.4 Europe Personalized Cell Therapy Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Personalized Cell Therapy Market Size (2015-2026)
• 8.2 Asia-Pacific Personalized Cell Therapy Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Personalized Cell Therapy Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Personalized Cell Therapy Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Personalized Cell Therapy Market Size (2015-2026)
• 9.2 Latin America Personalized Cell Therapy Market Size by Type (2015-2020)
• 9.3 Latin America Personalized Cell Therapy Market Size by Application (2015-2020)
• 9.4 Latin America Personalized Cell Therapy Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Personalized Cell Therapy Market Size (2015-2026)
• 10.2 Middle East & Africa Personalized Cell Therapy Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Personalized Cell Therapy Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Personalized Cell Therapy Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Novartis AG
  • 11.1.1 Novartis AG Company Details
  • 11.1.2 Novartis AG Business Overview
  • 11.1.3 Novartis AG Personalized Cell Therapy Introduction
  • 11.1.4 Novartis AG Revenue in Personalized Cell Therapy Business (2015-2020))
  • 11.1.5 Novartis AG Recent Development
• 11.2 Vericel Corporation
  • 11.2.1 Vericel Corporation Company Details
  • 11.2.2 Vericel Corporation Business Overview
  • 11.2.3 Vericel Corporation Personalized Cell Therapy Introduction
  • 11.2.4 Vericel Corporation Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.2.5 Vericel Corporation Recent Development
• 11.3 Bellicum Pharmaceuticals
  • 11.3.1 Bellicum Pharmaceuticals Company Details
  • 11.3.2 Bellicum Pharmaceuticals Business Overview
  • 11.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Introduction
  • 11.3.4 Bellicum Pharmaceuticals Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.3.5 Bellicum Pharmaceuticals Recent Development
• 11.4 MolMed SpA
  • 11.4.1 MolMed SpA Company Details
  • 11.4.2 MolMed SpA Business Overview
  • 11.4.3 MolMed SpA Personalized Cell Therapy Introduction
  • 11.4.4 MolMed SpA Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.4.5 MolMed SpA Recent Development
• 11.5 Cytori Therapeutics Inc
  • 11.5.1 Cytori Therapeutics Inc Company Details
  • 11.5.2 Cytori Therapeutics Inc Business Overview
  • 11.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Introduction
  • 11.5.4 Cytori Therapeutics Inc Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.5.5 Cytori Therapeutics Inc Recent Development
• 11.6 Gilead Sciences, Inc
  • 11.6.1 Gilead Sciences, Inc Company Details
  • 11.6.2 Gilead Sciences, Inc Business Overview
  • 11.6.3 Gilead Sciences, Inc Personalized Cell Therapy Introduction
  • 11.6.4 Gilead Sciences, Inc Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.6.5 Gilead Sciences, Inc Recent Development
• 11.7 Celgene Corporation
  • 11.7.1 Celgene Corporation Company Details
  • 11.7.2 Celgene Corporation Business Overview
  • 11.7.3 Celgene Corporation Personalized Cell Therapy Introduction
  • 11.7.4 Celgene Corporation Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.7.5 Celgene Corporation Recent Development
• 11.8 Bluebird Bio
  • 11.8.1 Bluebird Bio Company Details
  • 11.8.2 Bluebird Bio Business Overview
  • 11.8.3 Bluebird Bio Personalized Cell Therapy Introduction
  • 11.8.4 Bluebird Bio Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.8.5 Bluebird Bio Recent Development
• 11.9 Aurora Biopharma Inc
  • 11.9.1 Aurora Biopharma Inc Company Details
  • 11.9.2 Aurora Biopharma Inc Business Overview
  • 11.9.3 Aurora Biopharma Inc Personalized Cell Therapy Introduction
  • 11.9.4 Aurora Biopharma Inc Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.9.5 Aurora Biopharma Inc Recent Development
• 11.10 Saneron CCEL Therapeutics，Inc
  • 11.10.1 Saneron CCEL Therapeutics，Inc Company Details
  • 11.10.2 Saneron CCEL Therapeutics，Inc Business Overview
  • 11.10.3 Saneron CCEL Therapeutics，Inc Personalized Cell Therapy Introduction
  • 11.10.4 Saneron CCEL Therapeutics，Inc Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.10.5 Saneron CCEL Therapeutics，Inc Recent Development
• 11.11 Kuur Therapeutics
  • 10.11.1 Kuur Therapeutics Company Details
  • 10.11.2 Kuur Therapeutics Business Overview
  • 10.11.3 Kuur Therapeutics Personalized Cell Therapy Introduction
  • 10.11.4 Kuur Therapeutics Revenue in Personalized Cell Therapy Business (2015-2020)
  • 10.11.5 Kuur Therapeutics Recent Development
• 11.12 MediGene AG
  • 10.12.1 MediGene AG Company Details
  • 10.12.2 MediGene AG Business Overview
  • 10.12.3 MediGene AG Personalized Cell Therapy Introduction
  • 10.12.4 MediGene AG Revenue in Personalized Cell Therapy Business (2015-2020)
  • 10.12.5 MediGene AG Recent Development
• 11.13 Sangamo Therapeutics
  • 10.13.1 Sangamo Therapeutics Company Details
  • 10.13.2 Sangamo Therapeutics Business Overview
  • 10.13.3 Sangamo Therapeutics Personalized Cell Therapy Introduction
  • 10.13.4 Sangamo Therapeutics Revenue in Personalized Cell Therapy Business (2015-2020)
  • 10.13.5 Sangamo Therapeutics Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Personalized Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
By Cell Type
Hematopoietic Stem Cell
Skeletal Muscle Stem Cell
Mesenchymal Stem Cells
Lymphocytes
Others
By Technique
Platelet Transfusions
Bone Marrow Transplantation
Packed Red Cell Transfusions
Organ Transplantation

Market segment by Application, split into
Cardiovascular Diseases
Neurological Disorders
Inflammatory Diseases
Diabetes
Cancer
Others

Based on regional and country-level analysis, the Personalized Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE

In the competitive analysis section of the report, leading as well as prominent players of the global Personalized Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Novartis AG
Vericel Corporation
Bellicum Pharmaceuticals
MolMed SpA
Cytori Therapeutics Inc
Gilead Sciences, Inc
Celgene Corporation
Bluebird Bio
Aurora Biopharma Inc
Saneron CCEL Therapeutics，Inc
Kuur Therapeutics
MediGene AG